A detailed history of Horizon Kinetics Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 12,970 shares of AZN stock, worth $975,603. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,970
Previous 13,406 3.25%
Holding current value
$975,603
Previous $908,000 11.34%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $29,129 - $35,241
-436 Reduced 3.25%
12,970 $1.01 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $122 - $139
2 Added 0.01%
13,406 $908,000
Q4 2023

Feb 15, 2024

SELL
$61.89 - $69.28 $35,524 - $39,766
-574 Reduced 4.11%
13,404 $902,000
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $5,188 - $5,736
-80 Reduced 0.57%
13,978 $946,000
Q4 2022

Feb 07, 2023

SELL
$54.21 - $70.44 $56,053 - $72,834
-1,034 Reduced 6.85%
14,058 $953,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $1,802 - $4,615
34 Added 0.23%
15,092 $828,000
Q2 2022

Aug 05, 2022

SELL
$59.26 - $71.14 $12,148 - $14,583
-205 Reduced 1.34%
15,058 $995,000
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $193,680 - $240,720
-4,000 Reduced 20.77%
15,263 $914,000
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $97,040 - $116,040
-2,000 Reduced 9.41%
19,263 $963,000
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $151,160 - $205,320
-4,000 Reduced 15.83%
21,263 $950,000
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $896,583 - $1.09 Million
25,263 New
25,263 $1.02 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.